Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 913-924 of 1246 results.
"This study highlights the importance of minimizing CVC use and limiting the number of insertions to reduce CLABSI risk. Effective management strategies should focus on reducing CVC duration and frequency" Alomari et al (2025).
"Based on the results of this study, the use of combined non-pharmacological interventions of NSS has been more effective in reducing the pain caused by venous blood sampling than other conditions where two or one non-pharmacological intervention were used" Yadollahzadeh et al (2025).
"This study suggests that changing needles may not be necessary for maintaining sharpness if proper technique is used, potentially reducing the risk of needlestick injuries and medical waste" Tawil et al (2025).
"Micropuncture vascular access is increasingly being used in the intensive care unit (ICU) due to its perceived reduction of bleeding complications in common ICU procedures. The authors report two rare complications associated with micropuncture kit use associated with vascular access" Okamoto et al (2025).
"Peripheral vasopressors were commonly and safely used in our 10-hospital health system, particularly in the community hospitals. Peripheral initiation of vasopressors was not associated with increased mortality at 90 days, but was associated with decreased hospital length of stay" Shyu et al (2025).
"This study evaluates the effectiveness of polyhexamethylene biguanide (PHMB)-coated CVCs in reducing catheter-tip bacterial colonization in cancer patients undergoing abdominal surgery" Dong et al (2025).
"This report highlights the successful placement of a CV port by translumbar approach in a patient with advanced esophageal carcinoma complicated by SVCS" Maruo et al (2025).
"Although syringe preparation for large-volume (>3 mL) subcutaneous (SC) drugs represents a significant workflow burden for pharmacists, their preferences for alternatives such as on-body delivery systems (OBDSs) are unexplored" Desai et al (2025).
"Central Line-Associated Bloodstream Infection (CLABSI) remains a leading cause of death among critically ill patients. Implementing preventive measures and adhering to best practices is a crucial action to proactively prevent its occurrence" Mhawish et al (2025).
"This study aimed to analyze the influence factors affecting catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication, respectively, and to explore the relationship among them, as well as the influence of catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication on cancer patients' death" Weng et al (2025).
"This study examined differences in nosocomial-onset urinary tract-related bloodstream infections (UTRBSIs) and catheter-related bloodstream infections (CRBSIs) between patients admitted to long-term and acute care wards" Kumagai et al (2025).
"To reduce pain scores with intravenous (IV) insertion by 50% over 2 months among children in the ambulatory surgery center within a pediatric academic hospital" Merritt et al (2025).
